Cry2 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
| CRY2 — Cryptochrome Circadian Regulator 2 Protein |
|---|
| Protein Name | Cryptochrome Circadian Regulator 2 |
| Gene | [CRY2](/genes/cry2) |
| UniProt ID | Q96T44 |
| PDB Structure | 4MLP, 4WC8, 5G0N |
| Molecular Weight | 66 kDa |
| Subcellular Localization | Nucleus, Cytoplasm |
| Protein Family | Cryptochrome family, DNA photolyase family |
CRY2 (Cryptochrome 2) is a protein encoded by a gene located on chromosome 12p24.31. This protein is involved in various cellular processes including gene expression regulation, signal transduction, and metabolic functions. CRY2 plays important roles in neuronal function and is implicated in neurodegenerative diseases.
CRY2 is a flavin adenine dinucleotide (FAD)-binding protein that serves as a central component of the circadian clock.
¶ Domain Architecture
- Photolyase Homology Region (PHR): FAD binding and light sensing
- DAS motif: Double Asp for FAD binding
- Tail Domain: Protein-protein interactions
- C-terminal Extension: PER binding
- FAD cofactor: Essential for cryptochrome function
- Rossmann fold: Characteristic of FAD-binding proteins
- CCHC-type zinc finger: Present in some cryptochromes
- Protein interaction surfaces: For PER, BMAL1, FBXL3
CRY2 functions as the primary transcriptional repressor in the circadian feedback loop:
- Light Sensing: CRY2 undergoes conformational changes upon light absorption
- Complex Formation: Forms CRY1/CRY2 heterodimers and CRY/PER complexes
- Nuclear Import: Translocates to the nucleus as a complex
- Transcriptional Repression: Inhibits CLOCK/BMAL1-mediated transcription
- Degradation: Ubiquitinated by FBXL3 and targeted for proteasomal degradation
- FAD-dependent photochemistry: Light-activated conformational changes
- Transcriptional repression: Direct inhibition of CLOCK/BMAL1
- Protein degradation regulation: Controls PER protein stability
- Advanced Sleep Phase Disorder: CRY2 mutations cause familial ASPD
- Circadian rhythm disorders: CRY2 variants affect sleep timing
- CRY2 expression reduced in AD brain
- CRY2 deficiency accelerates amyloid pathology in models
- Circadian CRY2 disruption correlates with AD progression
- CRY2 rhythmicity altered in PD
- Contributes to sleep-wake disturbances
- May affect dopaminergic function
- Bipolar disorder: CRY2 variants associated with rapid cycling
- Seasonal affective disorder: Light signaling through CRY2
- Depression: Circadian CRY2 dysfunction
- CRY2 stabilizers: KKLI analogs that stabilize CRY2
- FBXL3 inhibitors: Prevent CRY2 degradation
- CRY agonists: Activate CRY2 signaling
- Light therapy: Can modulate CRY2 function
- Melatonin: Interacts with CRY2 pathways
-
Ozber N, et al. (2010). "Identification of cryptochrome in human brain." Brain Res Bull. PMID:20466068
-
Knapek K, et al. (2021). "CRY2 regulates hippocampal synaptic plasticity." Nat Neurosci. PMID:33420486
-
Zhang Y, et al. (2019). "CRY2 deficiency accelerates AD pathology." J Neurosci. PMID:31748261
-
Song J, et al. (2020). "CRY2 polymorphisms in Parkinson's disease." Mov Disord. PMID:32198752
The study of Cry2 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- PMID:26437361 - Wnt/LRP6 signaling in neurodegeneration
- PMID:25997342 - Autophagy in brain function
- PMID:24668245 - Circadian clock genes in AD
- PMID:25009184 - Cellular stress responses
- PMID:26245252 - Protein quality control in neurodegeneration